Walker Neal (CIK 1604457) reported 8 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-02-05). Recent activity: Buy ACRS (63,475 shares), Sell ACRS (18,611 shares), Buy ACRS (29,150 shares), Sell ACRS (9,952 shares), Buy ACRS (9,467 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-05 | Aclaris Therapeutics, Inc. (ACRS) | CEO | Buy | 63,475 | $0 |
| 2026-02-05 | Aclaris Therapeutics, Inc. (ACRS) | CEO | Sell | 18,611 | $64,580 |
| 2026-01-05 | Aclaris Therapeutics, Inc. (ACRS) | CEO | Buy | 29,150 | $0 |
| 2026-01-05 | Aclaris Therapeutics, Inc. (ACRS) | CEO | Sell | 9,952 | $28,662 |
| 2025-05-05 | Aclaris Therapeutics, Inc. (ACRS) | CEO | Buy | 9,467 | $0 |
| 2025-05-05 | Aclaris Therapeutics, Inc. (ACRS) | CEO | Sell | 2,975 | $4,106 |
| 2025-04-03 | Aclaris Therapeutics, Inc. (ACRS) | CEO | Buy | 9,467 | $0 |
| 2025-04-03 | Aclaris Therapeutics, Inc. (ACRS) | CEO | Sell | 3,042 | $4,502 |
来源：SEC Form 4 申报文件 · 截至 2026-02-05